Cargando…
Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
BACKGROUND: The lack of physiologically relevant and predictive cell-based assays is one of the major obstacles for testing and developing botulinum neurotoxins (BoNTs) therapeutics. Human-induced pluripotent stem cells (hiPSCs)-derivatives now offer the opportunity to improve the relevance of cellu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647380/ https://www.ncbi.nlm.nih.gov/pubmed/34865655 http://dx.doi.org/10.1186/s13287-021-02665-3 |
_version_ | 1784610594905653248 |
---|---|
author | de Lamotte, Juliette Duchesne Polentes, Jérôme Roussange, Florine Lesueur, Léa Feurgard, Pauline Perrier, Anselme Nicoleau, Camille Martinat, Cécile |
author_facet | de Lamotte, Juliette Duchesne Polentes, Jérôme Roussange, Florine Lesueur, Léa Feurgard, Pauline Perrier, Anselme Nicoleau, Camille Martinat, Cécile |
author_sort | de Lamotte, Juliette Duchesne |
collection | PubMed |
description | BACKGROUND: The lack of physiologically relevant and predictive cell-based assays is one of the major obstacles for testing and developing botulinum neurotoxins (BoNTs) therapeutics. Human-induced pluripotent stem cells (hiPSCs)-derivatives now offer the opportunity to improve the relevance of cellular models and thus the translational value of preclinical data. METHODS: We investigated the potential of hiPSC-derived motor neurons (hMNs) optical stimulation combined with calcium imaging in cocultured muscle cells activity to investigate BoNT-sensitivity of an in vitro model of human muscle-nerve system. RESULTS: Functional muscle-nerve coculture system was developed using hMNs and human immortalized skeletal muscle cells. Our results demonstrated that hMNs can innervate myotubes and induce contractions and calcium transient in muscle cells, generating an in vitro human motor endplate showing dose-dependent sensitivity to BoNTs intoxication. The implementation of optogenetics combined with live calcium imaging allows to monitor the impact of BoNTs intoxication on synaptic transmission in human motor endplate model. CONCLUSIONS: Altogether, our findings demonstrate the promise of optogenetically hiPSC-derived controlled muscle-nerve system for pharmaceutical BoNTs testing and development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02665-3. |
format | Online Article Text |
id | pubmed-8647380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86473802021-12-07 Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins de Lamotte, Juliette Duchesne Polentes, Jérôme Roussange, Florine Lesueur, Léa Feurgard, Pauline Perrier, Anselme Nicoleau, Camille Martinat, Cécile Stem Cell Res Ther Research BACKGROUND: The lack of physiologically relevant and predictive cell-based assays is one of the major obstacles for testing and developing botulinum neurotoxins (BoNTs) therapeutics. Human-induced pluripotent stem cells (hiPSCs)-derivatives now offer the opportunity to improve the relevance of cellular models and thus the translational value of preclinical data. METHODS: We investigated the potential of hiPSC-derived motor neurons (hMNs) optical stimulation combined with calcium imaging in cocultured muscle cells activity to investigate BoNT-sensitivity of an in vitro model of human muscle-nerve system. RESULTS: Functional muscle-nerve coculture system was developed using hMNs and human immortalized skeletal muscle cells. Our results demonstrated that hMNs can innervate myotubes and induce contractions and calcium transient in muscle cells, generating an in vitro human motor endplate showing dose-dependent sensitivity to BoNTs intoxication. The implementation of optogenetics combined with live calcium imaging allows to monitor the impact of BoNTs intoxication on synaptic transmission in human motor endplate model. CONCLUSIONS: Altogether, our findings demonstrate the promise of optogenetically hiPSC-derived controlled muscle-nerve system for pharmaceutical BoNTs testing and development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02665-3. BioMed Central 2021-12-05 /pmc/articles/PMC8647380/ /pubmed/34865655 http://dx.doi.org/10.1186/s13287-021-02665-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research de Lamotte, Juliette Duchesne Polentes, Jérôme Roussange, Florine Lesueur, Léa Feurgard, Pauline Perrier, Anselme Nicoleau, Camille Martinat, Cécile Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins |
title | Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins |
title_full | Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins |
title_fullStr | Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins |
title_full_unstemmed | Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins |
title_short | Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins |
title_sort | optogenetically controlled human functional motor endplate for testing botulinum neurotoxins |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647380/ https://www.ncbi.nlm.nih.gov/pubmed/34865655 http://dx.doi.org/10.1186/s13287-021-02665-3 |
work_keys_str_mv | AT delamottejulietteduchesne optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins AT polentesjerome optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins AT roussangeflorine optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins AT lesueurlea optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins AT feurgardpauline optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins AT perrieranselme optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins AT nicoleaucamille optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins AT martinatcecile optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins |